Evaluation of Juläine (TM) for the Treatment of Atrophic Facial Acne Scars

NANot yet recruitingINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

November 30, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

March 31, 2027

Conditions
Acne Scars
Interventions
DEVICE

Juläine

Juläine is a sterile injectable implant containing poly-L-lactic acid microspheres, intended for intradermal use to improve skin depressions from acne scars.

OTHER

Sterile Saline (Placebo)

Sterile saline solution used as a placebo control, administered in the same volume and schedule as Juläine.

Trial Locations (2)

Unknown

Individual Specialist Medical Practice Maria Luiza-Piesiaków, Gdansk

Centrum Medyczne dr Kubik, Gdynia

Sponsors
All Listed Sponsors
lead

Nordberg Medical AB

INDUSTRY

NCT07058883 - Evaluation of Juläine (TM) for the Treatment of Atrophic Facial Acne Scars | Biotech Hunter | Biotech Hunter